Sex differences in colorectal cancer: with a focus on sex hormone–gut microbiome axis
Cell Communication and Signaling · 07.03.2024 · 22 (1)
DOI: 10.1186/s12964-024-01549-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Communication and Signaling, online erschienen am 07.03.2024. Verfasst von Zihong Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colorectal Neoplasms. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Sichuan Province, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Sexual dimorphism has been observed in the incidence and prognosis of colorectal cancer (CRC), with men generally exhibiting a slightly higher incidence than women. Research suggests that this difference may be attributed to variations in sex steroid hormone levels and the gut microbiome. The gut microbiome in CRC shows variations in composition and function between the sexes, leading to the concept of ‘microgenderome’ and ‘sex hormone–gut microbiome axis.’ Conventional research indicates that estrogens, by promoting a more favorable gut microbiota, may reduce the risk of CRC. Conversely, androgens may have a direct pro-tumorigenic effect by increasing the proportion of opportunistic pathogens. The gut microbiota may also influence sex hormone levels by expressing specific enzymes or directly affecting gonadal function. However, this area remains controversial. This review aims to explore the differences in sex hormone in CRC incidence, the phenomenon of sexual dimorphism within the gut microbiome, and the intricate interplay of the sex hormone–gut microbiome axis in CRC. The objective is to gain a better understanding of these interactions and their potential clinical implications, as well as to introduce innovative approaches to CRC treatment. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Institute of Oncology, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. xiaochong@stu.cdutcm.edu.cn.
- TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. xiaochong@stu.cdutcm.edu.cn.
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. 2017202040046@whu.edu.cn.
Förderung
- Natural Science Foundation of Sichuan Province
- China Postdoctoral Science Foundation
Zitieren
APA
Wu, Z., Huang, Y., Zhang, R., Zheng, C., You, F., Wang, M., Xiao, C., & Li, X. (2024). Sex differences in colorectal cancer: with a focus on sex hormone–gut microbiome axis. Cell Communication and Signaling, 22(1). https://doi.org/10.1186/s12964-024-01549-2
Vancouver
Wu Z, Huang Y, Zhang R, Zheng C, You F, Wang M, et al. Sex differences in colorectal cancer: with a focus on sex hormone–gut microbiome axis. Cell Communication and Signaling. 2024;22(1). doi:10.1186/s12964-024-01549-2
BibTeX
@article{Wu2024,
author = {Wu, Zihong and Huang, Yuqing and Zhang, Renyi and Zheng, Chuan and You, Fengming and Wang, Min and Xiao, Chong and Li, Xueke},
title = {Sex differences in colorectal cancer: with a focus on sex hormone–gut microbiome axis},
journal = {Cell Communication and Signaling},
year = {2024},
volume = {22},
number = {1},
doi = {10.1186/s12964-024-01549-2}
}
EUVIMED